Genetics Unzipped podcast: The Future of Cancer: How Genomics is Transforming Research and Treatment for All
Posted by Kat Arney, on 24 September 2020
In this episode, sponsored by Thermo Fisher Scientific, we’re taking a look at how genomic technologies are transforming cancer care – now and in the future, and the importance of making sure that these advances are available to all.
We look at what the future looks like for both adult and childhood cancers, as well as exploring how important fast genetic testing is to patients and how new technology could help.
With guests:
- Greg Simon, past president of the Biden Cancer Initiative and former executive director of the White House Cancer Moonshot Task Force.
- Jim Downing – president and CEO of St Jude Children’s Research Hospital
- Dr Marianne Grantham, Head of Cytogenetics and Molecular Haematology department at the Royal London Hospital
- Kim Wood, Thermo Fisher Scientific’s Clinical Sequencing Division
If you’re a cancer researcher or cytogeneticist looking to use next generation sequencing in your work, fill in this simple form for more information about ThermoFisher’s next generation sequencing solutions.
Genetics Unzipped is the podcast from The Genetics Society. Full show notes, transcript, music credits and references online at GeneticsUnzipped.com.
Subscribe from Apple podcasts, Spotify, or wherever you get your podcasts.
And head over to GeneticsUnzipped.com to catch up on our extensive back catalogue.
Follow us on Twitter – @geneticsunzip
Image credit: DNA sequence of CCR5 Delta 32 gene mutation. Emei Ma, P/C Guy McLoughlin. Attribution 4.0 International (CC BY 4.0)
(No Ratings Yet)
Loading...
Faster and more precise DNA and RNA sequencing technology should definitely help scientists discover more about these diseases!